These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 15829410

  • 21. Radio-attenuated leishmanial parasites as immunoprophylactic agent against experimental murine visceral leishmaniasis.
    Datta S, Adak R, Chakraborty P, Haldar AK, Bhattacharjee S, Chakraborty A, Roy S, Manna M.
    Exp Parasitol; 2012 Jan; 130(1):39-47. PubMed ID: 22019416
    [Abstract] [Full Text] [Related]

  • 22. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LO, Tinoco LW, da Silva BP, Palatnik M, Parente JP, Palatnik-de-Sousa CB.
    Vaccine; 2006 May 01; 24(18):3909-20. PubMed ID: 16556475
    [Abstract] [Full Text] [Related]

  • 23. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM, Kuzin II, Lutsan NI, Lutsenko GV, Prokhorova AL, Sapozhnikov AM, Andronova TM, Ivanov VT.
    Biomed Sci; 1991 May 01; 2(6):651-8. PubMed ID: 1841635
    [Abstract] [Full Text] [Related]

  • 24. [Effect of novel derivatives of muramyl dipeptide on the immune system].
    Kaliuzhin OV, Fuks BB, Bovin NV, Zemliakov AE, Chirva VIa.
    Biull Eksp Biol Med; 1994 May 01; 117(5):510-3. PubMed ID: 9296705
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A.
    Vaccine; 2008 Oct 23; 26(45):5700-11. PubMed ID: 18762224
    [Abstract] [Full Text] [Related]

  • 29. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R, Gupta SK, Tripathi P, Hajela K, Sundar S, Naik S, Dube A.
    Vaccine; 2006 Apr 05; 24(15):2900-9. PubMed ID: 16448729
    [Abstract] [Full Text] [Related]

  • 30. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.
    Murray HW, Xiang Z, Ma X.
    Am J Trop Med Hyg; 2006 Jun 05; 74(6):1013-5. PubMed ID: 16760512
    [Abstract] [Full Text] [Related]

  • 31. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK, Das P.
    Exp Parasitol; 2009 Jan 05; 121(1):69-75. PubMed ID: 18948098
    [Abstract] [Full Text] [Related]

  • 32. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D, Pecar S, Kotnik V, Stalc A, Wraber-Herzog B, Simcic S, Ihan A, Klamfer L, Povsic L, Grahek R, Suhadolc E, Hocevar M, Hönig H, Rogi-Kohlenprath R.
    J Med Chem; 1998 Feb 12; 41(4):530-9. PubMed ID: 9484503
    [Abstract] [Full Text] [Related]

  • 33. Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.
    Mazumder S, Ravindran R, Banerjee A, Ali N.
    Vaccine; 2007 Dec 17; 25(52):8771-81. PubMed ID: 18031874
    [Abstract] [Full Text] [Related]

  • 34. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S, Ravindran R, Ali N.
    Vaccine; 2007 Aug 29; 25(35):6544-56. PubMed ID: 17655984
    [Abstract] [Full Text] [Related]

  • 35. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu, Stefanov AV, Los' GV, Andronova TM, Balitskiĭ KP.
    Dokl Akad Nauk SSSR; 1986 Aug 29; 286(2):474-6. PubMed ID: 3004870
    [No Abstract] [Full Text] [Related]

  • 36. Unresponsiveness of Mycobacterium w vaccine in managing acute and chronic Leishmania donovani infections in mouse and hamster.
    Tandon R, Misra P, Soni VK, Bano N, Misra-Bhattacharya S, Dube A.
    Parasitology; 2013 Apr 29; 140(4):435-44. PubMed ID: 23253783
    [Abstract] [Full Text] [Related]

  • 37. Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
    Adinolfi LE, Bonventre PF, Vander Pas M, Eppstein DA.
    Infect Immun; 1985 May 29; 48(2):409-16. PubMed ID: 3988341
    [Abstract] [Full Text] [Related]

  • 38. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
    Bhattacharjee S, Gupta G, Bhattacharya P, Mukherjee A, Mujumdar SB, Pal A, Majumdar S.
    J Antimicrob Chemother; 2009 Feb 29; 63(2):317-24. PubMed ID: 19036753
    [Abstract] [Full Text] [Related]

  • 39. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
    Liu C, Xi T, Lin Q, Xing Y, Ye L, Luo X, Wang F.
    Int Immunopharmacol; 2008 Dec 20; 8(13-14):1835-41. PubMed ID: 18834960
    [Abstract] [Full Text] [Related]

  • 40. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M, Gupta R, Kumari S, Misra P, Khare P, Kushawaha PK, Sahasrabuddhe AA, Dube A.
    J Immunol; 2009 Jul 01; 183(1):470-9. PubMed ID: 19542458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.